Thyroïdinum/Thyroïde/Thyroidea
Natural health product licensed in Canada
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80022043
- Status
- Active licence
- Licence date
- 2 November 2010
- Revision date
- Not provided
- Form
- Globules
- Route of administration
- Sublinguale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Sus scrofa Source : Glande thyroïde | 4 CH |
Non-medicinal ingredients
Lactose, Saccharose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 12 years | 1 Tube | 1 Tous les jours |
Uses authorised in Canada
Préparation d`organothérapie à être utilisée sur l`avis d`un praticien de la santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de la santé si les symptômes persistent ou s`aggravent. Consultez un praticien de la santé avant l`usage si vous souffrez de maladie du foie, d`épilepsie.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez sauf sur l`avis d`un praticien de la santé.
- Effets indésirables connus
Aucune connue.
Source
Official Health Canada record, licence 80022043
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.